TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Roche Diagnostics Norge AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,593,258
|
1,023,355
|
454,995 |
Financial expenses |
929
|
523
|
761 |
Earnings before taxes |
74,268
|
15,876
|
17,706 |
Total assets |
256,213
|
487,296
|
242,721 |
Current assets |
222,938
|
476,535
|
229,249 |
Current liabilities |
189,645
|
403,248
|
174,407 |
Equity capital |
66,568
|
84,048
|
68,315 |
- share capital |
4,126
|
4,354
|
4,132 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
26.0%
|
17.2%
|
28.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.7%
|
1.6%
|
3.9% |
Return on assets (ROA) |
29.3%
|
3.4%
|
7.6% |
Current ratio |
117.6%
|
118.2%
|
131.4% |
Return on equity (ROE) |
111.6%
|
18.9%
|
25.9% |
Change turnover |
623,655
|
543,843
|
74,782 |
Change turnover % |
64%
|
113%
|
20% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.